TCL Archive Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups March 21, 1986
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983